Daratumumab, Bortezomib, and Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) Alone in Chinese Patients with Relapsed/Refractory Multiple Myeloma: Final Analysis of the Phase 3 Lepus Study

Fu, WJ; Gai, X; Liu, WP; Chen, X; Cui, CC; Lu, J

BLOOD, 2023; 142 ():